Remote Monitoring in Diabetes Disease Management

A Randomized Study of the Clinical and Economic Impact of Remote Monitoring Program With Disease Management Compared to Conventional Diabetes Disease Management Interventions

The primary objective of this study is to determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease than a standard disease management program.

To determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease.

Inclusion Criteria

• Between 18 and 64 years of age as of January 1, 2008
• Diagnosis of diabetes mellitus (listed ICD-9-CM diagnosis code on two or more outpatient claims, or on one or more inpatient admissions or emergency room claims in the most recent 12-month period)
• Continuously enrolled in a health plan with pharmacy and medical benefits for the most recent 12-month period or with one period of non-enrollment up to only 30 days
• Able to provide written informed consent for study participation

Exclusion Criteria

• Advanced renal disease (one or more claims in the most recent 12-month period) as defined by a claim for nephropathy or creatinine greater than 2.5 mg/dl
• Selected cancers (one or more claims in the most recent 12-month period)
• HIV/AIDS (one or more claims in the most recent 12-month period)
• Heart, liver, kidney, or multiple organ transplant (one or more claims in the most recent 12-month period)
• Cirrhosis of the liver (one or more claims in the most recent 12-month period)
• Current participation in another LifeScan study or other diabetes-related clinical trials
• Medicare is primary source of insurance coverage
• Unable to understand written and spoken English